Drug Type CRISPR/Cas9 |
Synonyms |
Target |
Mechanism Hemoglobin HbA modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alpha-Thalassemia | Phase 1 | CN | 08 Oct 2022 |